Chemours Company

Chemours is a provider of performance chemicals. The company has three reportable segments: Fluoroproducts, Chemical Solutions, and Titanium Technologies. The company's Fluoroproducts segment is a provider of fluoroproducts, including refrigerants and industrial fluoropolymer resins. The company's Chemical Solutions segment is a North American provider of industrial chemicals used in gold production, industrial, and consumer applications. The company's Titanium Technologies segment is a provider of titanium dioxide pigment, a white pigment used to deliver whiteness, brightness, opacity, and protection in a variety of applications.
  • TickerCC
  • ISINUS1638511089
  • ExchangeNew York Stock Exchange
  • SectorChemicals
  • CountryUnited States

Chemours Company, (The): Update to credit analysis

Our credit view of Chemours Company, reflecting its growing case load of PFAS litigation, mitigated by the liability agreement, relatively unchanged debt level and its cyclical TiO2 Industry

CHEMOURS sees a downgrade to Slightly Negative on account of less fundamental stars

The independent financial analyst theScreener just lowered the general evaluation of CHEMOURS (US), active in the Commodity Chemicals industry. As regards its fundamental valuation, the title now shows 3 out of 4 stars while market behaviour can be considered risky. theScreener believes that the title remains under pressure due to the loss of a star(s) and downgrades its general evaluation to Slightly Negative. As of the analysis date February 9, 2021, the closing price was USD 27.29 and its target price was estimated at USD 16.93.

Moody's says DuPont, Chemours and Corteva PFAS liability cost sharing MOU and Ohio MDL settlement will have no impact on any ratings or outlooks

Announcement: Moody's says DuPont, Chemours and Corteva PFAS liability cost sharing MOU and Ohio MDL settlement will have no impact on any ratings or outlooks. Global Credit Research- 25 Jan 2021. New York, January 25, 2021-- Moody's Investors Service stated that the memorandum of understanding regarding the cost sharing of potential future PFAS liabilities between DuPont de Nemours, Inc., E.I. du Pont de Nemours and Company and The Chemours Company that provides greater...

MarketLine Department

Olin Corporation - Strategy, SWOT and Corporate Finance Report

Summary Olin Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Olin Corporation (Olin or 'the company') is a manufacturer and distributor of chemical products and a manufacturer of ammunition. It offers a range of products and services under the Chlor Products and Vinyls, Epoxy, and Winchester business lines. The Chlor Alkali Products and Vinyls produc...

Moody's assigns B1 to Chemours' New Senior Unsecured Notes

Rating Action: Moody's assigns B1 to Chemours' New Senior Unsecured Notes. Global Credit Research- 12 Nov 2020. New York, November 12, 2020-- Moody's Investors Service assigned a B1 rating to $750 million in new senior unsecured notes due 2028 by The Chemours Company.

Dave Nicoski ...
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • The U.S. dollar has been unable to break to new highs and is vulnerable. We continue to believe that emerging markets and materials, especially gold are likely to benefit from a weakening U.S. dollar. This market resembles late 2015-early 2016 emerging market rout. • High yield corporate bonds are showing some stabilization as 10-year treasury yields moved to another low in face of the Fed tightening. • A number of Biotechs are indicating reversals and hitting multi-month RS highs.

Matthieu DRIOL

Analyse court terme - CHEMOURS : La tendance de fond est clairement orientée à la baisse.

La tendance de fond est clairement orientée à la baisse. Le MACD est négatif, il confirme cette tendance. La reprise est une consolidation qui va buter sur 46,35 $ prochainement. Le prochain objectif est à 38,36 $, puis 34,56 $. Le franchissement de 52,86 $ remettrait en cause la suite de la baisse.

Matthieu DRIOL

Short term view - CHEMOURS : The background trend is clearly bearish.

The background trend is clearly bearish. The negative MACD confirms the trend. The rise is a consolidation that will soon bump against the level at $46.35. The next target is at $38.36, then $34.56. Passing $52.86 would question the continuation of the fall.

1 director bought

A director at Chemours Co bought 20,000 shares at 16.417USD and the significance rating of the trade was 61/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board ...

MarketLine Department

Olin Corporation - Strategy, SWOT and Corporate Finance Report

Summary Olin Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Olin Corporation (Olin or 'the company') is a manufacturer and distributor of chemical products and a manufacturer of ammunition. It offers a range of products and services under the Chlor Products and Vinyls, Epoxy, and Winchester business lines. The Chlor Alkali Products and Vinyls produc...

MarketLine Department

Argex Titanium Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances And Investments

Summary Marketline's Argex Titanium Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Argex Titanium Inc. since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage....

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Chemours Company, (The): Update to credit analysis

Our credit view of Chemours Company, reflecting its growing case load of PFAS litigation, mitigated by the liability agreement, relatively unchanged debt level and its cyclical TiO2 Industry

Moody's says DuPont, Chemours and Corteva PFAS liability cost sharing MOU and Ohio MDL settlement will have no impact on any ratings or outlooks

Announcement: Moody's says DuPont, Chemours and Corteva PFAS liability cost sharing MOU and Ohio MDL settlement will have no impact on any ratings or outlooks. Global Credit Research- 25 Jan 2021. New York, January 25, 2021-- Moody's Investors Service stated that the memorandum of understanding regarding the cost sharing of potential future PFAS liabilities between DuPont de Nemours, Inc., E.I. du Pont de Nemours and Company and The Chemours Company that provides greater...

Moody's assigns B1 to Chemours' New Senior Unsecured Notes

Rating Action: Moody's assigns B1 to Chemours' New Senior Unsecured Notes. Global Credit Research- 12 Nov 2020. New York, November 12, 2020-- Moody's Investors Service assigned a B1 rating to $750 million in new senior unsecured notes due 2028 by The Chemours Company.

Moody's assigns B1 to Chemours' New Senior Unsecured Notes

Rating Action: Moody's assigns B1 to Chemours' New Senior Unsecured Notes. Global Credit Research- 12 Nov 2020. New York, November 12, 2020-- Moody's Investors Service assigned a B1 rating to $750 million in new senior unsecured notes due 2028 by The Chemours Company.

Moody's announces completion of a periodic review of ratings of Chemours Company, (The)

Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Chemours Company,. Global Credit Research- 07 Oct 2020. New York, October 07, 2020-- Moody's Investors Service has completed a periodic review of the ratings of Chemours Company, and other ratings that are associated with the same analytical unit.

CHEMOURS sees a downgrade to Slightly Negative on account of less fundamental stars

The independent financial analyst theScreener just lowered the general evaluation of CHEMOURS (US), active in the Commodity Chemicals industry. As regards its fundamental valuation, the title now shows 3 out of 4 stars while market behaviour can be considered risky. theScreener believes that the title remains under pressure due to the loss of a star(s) and downgrades its general evaluation to Slightly Negative. As of the analysis date February 9, 2021, the closing price was USD 27.29 and its target price was estimated at USD 16.93.

Ford Equity US Rating and Forecast Report

Ford Equity Research covers more than 4,000 stocks using a proprietary quantitative model that evaluates a company’s earnings strength, its relative valuation and recent price movement. Ford’s five recommendation ratings include strong buy, buy, hold, sell, strong sell. For all stocks in our coverage universe, ratings are generated each week and reflect the fundamental and price data as of the last trading day of the week.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch